Pfizer Considers Cost Cuts as Demand for COVID Products Falls
Pfizer on Tuesday said it will launch a cost-cutting program if its COVID-19 vaccine and antiviral treatment keep underperforming expectations in the coming months due to plunging demand.
Source: medscape.com